Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes

Journal of Pediatrics

Volumn 149, Issue 3, 2006, Pages 320-323

  Gunczler, Peter ^a   Lanes, Roberto ^a   Soros, Arlette ^a   Verdu, Livia ^a   Ramon, Yolanda ^a   Guevara, Beatriz ^a   Beer, Nusen ^a  

^a Hospital de Clinicas Caracas   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPID; LIPOPROTEIN; METALLOPROTEINASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTERY CALCIFICATION; ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EVALUATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; APOLIPOPROTEINS B; C-REACTIVE PROTEIN; CALCINOSIS; CASE-CONTROL STUDIES; CHILD; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LIPIDS; MALE; MATRIX METALLOPROTEINASE 9;

EID: 33747890821     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.04.064     Document Type: Article

References (22)

1. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. the Framingham Study. JAMA 241 (1979) 2035-2038
2. Whiteley L., Padmanabhan S., Hole D., and Isles C. Should diabetes be considered a coronary heart disease risk equivalent?. Diabetes Care 28 (2005) 1588-1593
3. Parikh A., Sochett E.B., McCrindle B.W., Dipchand A., Daneman A., and Daneman D. Carotid distensibility and cardiac function in adolescents with type 1 diabetes. J Pediatr 137 (2000) 465-469
4. Peppa-Patrikiou M., Scordili M., Antoniou A., Giannaki M., Dracopoulou M., and Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Diabetes Care 21 (1998) 1004-1007
5. Krantz J.S., Mack W.J., Hodis H.N., Liu C.-R., Liu C.-H., and Kaufman F.R. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 145 (2004) 452-457
6. Gunczler P., Lanes R., Lopez E., Esaa S., Villaroel O., and Revel-Chon R. Cardiac mass and function, carotid artery intima-media thickness and lipoprotein (a) levels in children and adolescents with type 1 diabetes mellitus of short duration. J Pediatr Endocrinol Metab 15 (2002) 181-186
7. Verges B.L. Dyslipidemia in diabetes mellitus. review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab 25 suppl 3 (1999) 32-40
8. Deveraj S., O'Keefe G., and Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab 90 (2005) 4549-4554
9. Jialal I., Devaraj S., and Venugopal S.K. C-reactive protein. risk marker or mediator in atherothrombosis?. Hypertension 44 (2004) 6
10. Detrano R.C., Doherty T.M., Davis M.J., and Stary H.C. Predicting coronary events with coronary calcium. pathophysiologic and clinical problems. Curr Probl Cardiol 25 (2000) 374-402
11. Meigs J.B., Larson M.G., D'Agostino R.B., Levy D., Clouse M.E., Nathan D.M., et al. Coronary artery calcification in type 2 diabetes and insulin resistance. the Framingham offspring study. Diabetes Care 25 (2002) 1313-1319
12. Dabelea D., Kinney G., Snell-Bergeon J.K., Hokanson J.E., Eckel R.H., Ehrlich J., et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACT1) Study. Diabetes 52 (2003) 2833-2839
13. Starkman H.S., Cable G., Ala V., Hecht H., and Donnelly C.M. Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care 26 (2003) 433-436
14. Freedman D.S., Srinivasan S.R., Shear C.L., Franklin F.A., Webber L.S., and Behrenson G.S. The relation of apolipoproteins A-1 and B in children to parental myocardial infarction. N Engl J Med 315 (1986) 721-727
15. Jialal I., Devaraj S., and Venugopal S.K. C-reactive protein. risk marker or mediator in atherothrombosis?. Hypertension 44 (2004) 6-11
16. Roombereger J.A., Brundage B.H., Rader D.J., and Condos G. Electron beam computed tomographic coronary calcium scanning. a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74 (1999) 243-252
17. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
18. Tsuchiya M., Suzuki E., Egawa K., Nishio H., Inoue S., Mitsunami K., et al. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care 27 (2004) 2409-2415
19. Tayebjee M.H., Lim H.S., MacFadyen R.J., and Lip G.Y.H. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes. effect of 1 year's cardiovascular risk reduction therapy. Diabetes Care 27 (2005) 2049-2051
20. Maahs D.M., Maniatis A.K., Nadeau K., Wadwa P., McFann K., and Klingensmith G.J. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr 147 (2005) 544-546
21. Selvin E., Coresh J., Golden S.H., Boland L.L., Brancati F.L., and Steffes M.W. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes. Diabetes Care 28 (2005) 1965-1973
22. Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653